A Study to Determine the Safety and Sensitizing Potential of HAT1 Topical Products Using Skin Sensitivity Patch Tests

Clinical trial NCT03406117 · COMPLETED

Trial details

NCT number: NCT03406117
Sponsor: Haus Bioceuticals
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Healthy Atopic Dermatitis Psoriasis

Start date: 2016-04-01
Primary completion: 2016-06-26
Enrollment: 182

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.